Japanese Encephalitis Outbreak, Yuncheng, China, 2006

1. Paterson DL, Bonomo RA. Extendedspectrum beta-lactamases: a clinical update. Clin Microbiol Rev. 2005;18: 657–86. 2. Livermore DM, Canton R, Gniadkowski M, Nordmann P, Rossolini GM, Arlet G, et al. CTX-M: changing the face of ESBLs in Europe. J Antimicrob Chemother. 2007; [Epub 2006 Dec 6]. 3. Pitout JD, Gregson DB, Church DL, Elsayed S, Laupland KB. Community-wide outbreaks of clonally related CTX-M-14 beta-lactamase–producing Escherichia coli strains in the Calgary health region. J Clin Microbiol. 2005;43:2844–9. 4. Moland ES, Black JA, Hossain A, Hanson ND, Thomson KS, Pottumarthy S. Discovery of CTX-M-like extended-spectrum beta-lactamases in Escherichia coli isolates from fi ve U.S. states. Antimicrob Agents Chemother. 2003;47:2382–3. 5. Livermore DM, Hawkey PM. CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother. 2005;56:451–4. 6. Rodriguez-Bano J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, et al. Epidemiology and clinical features of infections caused by extendedspectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol. 2004;42:1089–94. 7. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436–44. 8. Meunier D, Jouy E, Lazizzera C, Kobisch M, Madec JY. CTX-M-1 and CTX-M-15 type beta-lactamases in clinical Escherichia coli isolates recovered from foodproducing animals in France. Int J Antimicrob Agents. 2006;28:402–7.